Insider: Sethuraman Natarajan President, Research & Develop. - Entrada Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 144,997 | 0 | 144,997 |
| Value | $809,083.26 | $0.00 | $809,083.26 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/03/2024 | DDS | 11,703 | Direct | COM | $20.15 | $235,786.19 | 144,997 |
| 12/02/2024 | DDS | 4,088 | Direct | COM | $20.26 | $82,833.51 | 156,700 |
| 11/29/2024 | DDS | 100 | Direct | COM | $20.00 | $2,000.00 | 160,788 |
| 11/13/2024 | DDS | 2,700 | Direct | COM | $20.04 | $54,108.81 | 160,888 |
| 11/11/2024 | DDS | 1,409 | Direct | COM | $20.01 | $28,191.13 | 163,588 |
| 11/06/2024 | DDS | 2,745 | Direct | COM | $19.32 | $53,023.52 | 164,997 |
| 11/06/2024 | DDS | 9,554 | Direct | COM | $18.71 | $178,752.47 | 167,742 |
| 11/05/2024 | DDS | 5,171 | Direct | COM | $18.18 | $94,006.19 | 177,296 |
| 11/04/2024 | DDS | 749 | Direct | COM | $18.02 | $13,498.48 | 182,467 |
| 10/16/2024 | DDS | 600 | Direct | COM | $18.00 | $10,800.00 | 183,216 |
| 09/09/2024 | DDS | 2,642 | Direct | COM | $15.09 | $39,862.23 | 183,816 |
| 09/06/2024 | DDS | 600 | Direct | COM | $15.24 | $9,141.36 | 186,458 |
| 07/15/2024 | DDS | 638 | Direct | COM | $18.00 | $11,484.00 | 188,814 |
| 07/12/2024 | DDS | 600 | Direct | COM | $18.00 | $10,800.00 | 189,452 |
| 05/20/2024 | DDS | 9,675 | Direct | COM | $15.19 | $146,943.90 | 190,052 |
| 05/17/2024 | DDS | 8,305 | Direct | COM | $15.14 | $125,750.99 | 199,727 |
| 05/16/2024 | DDS | 1,000 | Direct | COM | $15.00 | $15,000.00 | 208,032 |
| 07/11/2023 | DDS | 14,852 | Direct | COM | $18.04 | $267,915.23 | 153,447 |
| 07/10/2023 | DDS | 3,026 | Direct | COM | $18.00 | $54,474.05 | 168,299 |
| 04/17/2023 | DDS | 3,961 | Direct | COM | $18.00 | $71,315.82 | 171,325 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research